Price
No data yet.
Social Signal Score
Revenue
$20.23B+32.43%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Samuel N. Hazen
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 320,000
- Beta
- 1.11
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 2.55
Financials
Revenue
$20.23B+32.4%Net Income
$1.70B-25.1%EBITDA
$4.01B-6.1%Free Cash Flow
$1.10B-20.5%EPS (diluted)
$7.62+8.9%Shares Outstanding (diluted)
222.83M-31.2%Operating Expenses
$8.29BCash & Debt
$1.01BReturn of Capital
$2.23BRevenue by Segment (annual)
$73.14BDividend per Share
$0.78Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $75.60B | $6.78B | $28.62 |
| 2024 | $70.60B | $5.76B | $22.27 |
| 2023 | $64.97B | $5.24B | $19.24 |
| 2022 | $60.23B | $5.64B | $19.44 |
| 2021 | $58.75B | $6.96B | $21.51 |
| 2020 | $51.53B | $3.75B | $11.08 |
| 2019 | $51.34B | $3.50B | $10.27 |
| 2018 | $46.68B | $3.79B | $11.04 |
| 2017 | $43.61B | $2.22B | $6.33 |
| 2016 | $41.49B | $2.89B | $7.80 |
| 2015 | $39.68B | $2.13B | $5.34 |
| 2014 | $36.92B | $1.88B | $4.46 |
| 2013 | $34.18B | $1.56B | $3.54 |
| 2012 | $33.01B | $1.60B | $3.62 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HCA's reported EPS growth of 17.2% a year over 13 years.
- EPS in 5 years
- $65.02
- Implied price
- $1,040
- Return from $406.27
- 20.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $517.24 — today's price is already 21.5% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 14 | 16 | 18 | 20 |
|---|---|---|---|---|---|
| 7.2% | 4.2% | 7.5% | 10.4% | 13.0% | 15.4% |
| 12.2% | 9.1% | 12.5% | 15.5% | 18.3% | 20.8% |
| 17.2% | 13.9% | 17.5% | 20.7% | 23.6% | 26.2% |
| 22.2% | 18.8% | 22.5% | 25.8% | 28.8% | 31.6% |
| 27.2% | 23.7% | 27.5% | 31.0% | 34.1% | 37.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100Social Signal Score
Mentions (1)
- Newsbusinesswire.com·6h ago·Neutral
HCA Healthcare, Inc. to Present at September Conferences NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the…
View source ↗
Earnings
Fri, Oct 23(in 2 months)
Consensus estimate $6.75 per share
Typical surprise +7.4% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Jul 24$7.59 vs $7.56beat
- Fri, Apr 24$7.15 vs $7.12beat
- Tue, Jan 27$8.01 vs $7.46beat
- Fri, Oct 24$6.96 vs $5.79beat
- Fri, Jul 25$6.84 vs $6.29beat
- Fri, Apr 25$6.45 vs $5.75beat
Estimates and results for HCA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HCA officers and directors.
- Bought
- —
- Sold
- $32.7m
0 trades
14 trades
- Mcalevey Michael Rsold
- Wyatt Christopher F.sold
- Berres Jennifersold
- Berres Jennifersold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
- Hazen Samuel Nsold
86 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.